A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): a Galician Lung Cancer Group (GGCP) study.

Firvida Perez, Jose Luis; Vázquez Estévez, Sergio; Campos Balea, Begoña; Barón Duarte, Francisco Javier; Alonso-Jaudenes Curbera, Guillermo
Thumbnail
Statistics
Statistics
Identifiers
Identifiers
URI: http://hdl.handle.net/20.500.11940/6329
PMID: 24352251
ISSN: 0344-5704
Full record
Services
Services
RISMendeleyLinksolver
Date issued
2014
Journal title
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Type of content
Artigo